K E Tranbarger Freier

Suggest Changes
We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
10058 Background: OS is the generally accepted measure of efficacy in cancer trials because it is clinically meaningful and objectively measured. However, using OS as a primary endpoint in RCTs(More)
  • 1